Fibulin-3 as a biomarker of response to treatment in malignant mesothelioma

BACKGROUND: Fibulin-3 is a new potential biomarker for malignant mesothelioma (MM). This study evaluated the potential applicability of fibulin-3 plasma levels as a biomarker of response to treatment and its prognostic value for progressive disease within 18 months. The potential applicability of fi...

Full description

Saved in:
Bibliographic Details
Published in:Radiol Oncol
Main Authors: Kovac, Viljem, Dodic-Fikfak, Metoda, Arneric, Niko, Dolzan, Vita, Franko, Alenka
Format: Artigo
Language:Inglês
Published: Versita, Warsaw 2015
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4577225/
https://ncbi.nlm.nih.gov/pubmed/26401134
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1515/raon-2015-0019
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items